Scholarlink

<p>Serrated polyps, key precursors in up to 30% of colorectal cancer (CRC) cases, present substantial diagnostic challenges due to morphological similarities, especially between sessile serrated adenomas/polyps or sessile serrated lesions (SSLs) and hyperplastic polyps (HPs). Current histopathological methods often fail to reliably differentiate these lesions, with diagnostic accuracy rates as low as 70–85%. This underscores the urgent need for molecular markers to facilitate early detection and surveillance of CRC. We integrated RNA sequencing datasets (GSE76987, GSE46513, ERP109626) using meta-analysis to identify differentially expressed genes (DEGs) distinguishing SSL from HPs. Candidate genes (FOXQ1, GRIN2D, SCNN1B) were validated using quantitative real-time PCR (qPCR) on 30 SSLs, HPs, adjacent normal tissues, and 15 CRC samples. FOXQ1 and GRIN2D were significantly upregulated in SSLs and CRC samples compared to HPs and normal tissues (<i>P</i> &lt; 0.0001), while SCNN1B was consistently downregulated (<i>P</i> = 0.0045). These gene expression patterns were consistent across both bioinformatics and wet-lab analyses. This integrative approach identified FOXQ1, GRIN2D, and SCNN1B as promising molecular biomarkers for distinguishing high-risk SSLs from HPs. These genes hold potential for enhancing diagnostic accuracy and early CRC detection. Further functional studies are warranted to explore their roles in serrated neoplasia and clinical application in CRC risk assessment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Integrated bioinformatics and experimental validation identify FOXQ1, GRIN2D, and SCNN1B as novel biomarkers for distinguishing high-risk sessile serrated lesions from hyperplastic polyps

  • 期刊论文

  • 发表日期：

    2026年1月17日

查看全文
  • Nayeralsadat Fatemi,
  • Zeynab Piryaei,
  • Elahe Daskar Abkenar,
  • Elham Zonoobi,
  • Nada Badr,
  • Ali Aghaei,
  • Seyedeh Nasim Mirbahari,
  • Ebrahim Mirzaei,
  • Maryam Parvizi,
  • Mahsa Saeedi Niasar,
  • Pardis Ketabi Moghadam,
  • Amir Sadeghi,
  • Peter J. K. Kuppen,
  • Ehsan Nazemalhosseini-Mojarad

摘要

Serrated polyps, key precursors in up to 30% of colorectal cancer (CRC) cases, present substantial diagnostic challenges due to morphological similarities, especially between sessile serrated adenomas/polyps or sessile serrated lesions (SSLs) and hyperplastic polyps (HPs). Current histopathological methods often fail to reliably differentiate these lesions, with diagnostic accuracy rates as low as 70–85%. This underscores the urgent need for molecular markers to facilitate early detection and surveillance of CRC. We integrated RNA sequencing datasets (GSE76987, GSE46513, ERP109626) using meta-analysis to identify differentially expressed genes (DEGs) distinguishing SSL from HPs. Candidate genes (FOXQ1, GRIN2D, SCNN1B) were validated using quantitative real-time PCR (qPCR) on 30 SSLs, HPs, adjacent normal tissues, and 15 CRC samples. FOXQ1 and GRIN2D were significantly upregulated in SSLs and CRC samples compared to HPs and normal tissues (P < 0.0001), while SCNN1B was consistently downregulated (P = 0.0045). These gene expression patterns were consistent across both bioinformatics and wet-lab analyses. This integrative approach identified FOXQ1, GRIN2D, and SCNN1B as promising molecular biomarkers for distinguishing high-risk SSLs from HPs. These genes hold potential for enhancing diagnostic accuracy and early CRC detection. Further functional studies are warranted to explore their roles in serrated neoplasia and clinical application in CRC risk assessment.